Skip to main content
Caplight Logo









CureCurve Medical AI

CureCurve Medical AI

Private
MannheimHealthcare & Life Scienceshttps://curecurve.de/

Last Round

Pre Seed

May 25, 2022

Company Overview

CureCurve Medical AI is a health technology company that develops AI-powered digital therapy solutions for the management and prevention of chronic cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Patient Engagement, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital health applicationDiGAdigital therapeuticsDTxcoronary heart diseasechronic disease managementpatient adherencemedical AIapps on prescriptioncardiovascular healthsymptom trackinglifestyle interventionB2B2Chealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureCurve Medical AI Comparables

Compare CureCurve Medical AI with similar companies based on industry and business-model similarity.

CureCurve Medical AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pathmate Technologies
85%
Mio Health UG
84%
ProCarement
83%

CureCurve Medical AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 25, 2022

Key People

Founding team and executive leadership

Deniz Yologlu

Co-Founder, Gesellschafter, CTO

Founding Team

Tiziano Bruno

CEO und Co-founder

Founding Team

CureCurve Medical AI Investors

Notable investors and investment history

CureCurve Medical AI investors
InvestorRounds
State of Baden-WürttembergPre Seed
L-BankPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 25, 2022

    Secured funding from L-Bank and State of Baden-Württemberg.

CureCurve Medical AI Filings

Explore SEC and related filing metadata, where available.

CureCurve Medical AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CureCurve Medical AI's valuation, stock price, and market status.

Is CureCurve Medical AI a public or private company?

CureCurve Medical AI is a private company.

What is the current stock price of CureCurve Medical AI?

CureCurve Medical AI is a private company with no public stock price. Caplight tracks CureCurve Medical AI's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is CureCurve Medical AI worth (valuation)?

Valuation information for CureCurve Medical AI is not publicly available.

Can I buy CureCurve Medical AI stock?

CureCurve Medical AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CureCurve Medical AI's last funding round?

CureCurve Medical AI's most recent funding round was Pre Seed on May 25, 2022.

Who are the main investors in CureCurve Medical AI?

Key investors in CureCurve Medical AI include State of Baden-Württemberg, L-Bank.

Will CureCurve Medical AI IPO soon?

No public IPO plans have been announced for CureCurve Medical AI.

How can I track CureCurve Medical AI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureCurve Medical AI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMannheim
Employee Range3
Year Founded2021
Last FundingMay 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?